Impact of a functionalized olive oil extract on the uterus and the bone in a model of postmenopausal osteoporosis

European Journal of Nutrition

Volumn 53, Issue 4, 2014, Pages 1073-1081

  Keiler, Annekathrin Martina ^a   Zierau, Oliver ^a   Bernhardt, Ricardo ^a   Scharnweber, Dieter ^a   Lemonakis, Nikolaos ^b   Termetzi, Aikaterini ^b   Skaltsounis, Leandros ^b   Vollmer, Günter ^a   Halabalaki, Maria ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Extra virgin olive oil; Oleacein; Oleocanthal; Osteoporosis; Polyphenolic fraction

Indexed keywords

COMPLEMENT COMPONENT C3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXTRA VIRGIN OLIVE OIL PHENOLIC EXTRACT; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; OLEOCANTHAL; OLIVE OIL; POLYPHENOL; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; ALDEHYDE; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR; PHENOL DERIVATIVE; PLANT EXTRACT; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE; BONE MASS; BONE STRUCTURE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; HORMONE RECEPTOR INTERACTION; IC 50; LEWIS RAT; MARKER GENE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OVARIECTOMY-INDUCED OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UTERUS; UTERUS WEIGHT; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; ORGAN SIZE; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY;

RATTUS;

ALDEHYDES; ANIMALS; BONE AND BONES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; ORGAN SIZE; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHENOLS; PLANT EXTRACTS; PLANT OILS; POLYPHENOLS; RATS; RATS, INBRED LEW; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; UTERUS;

EID: 84903479682     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0609-4     Document Type: Article

References (51)

1. Buckland G, Travier N, Cottet V et al (2012) Adherence to the Mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer. doi:10.1002/ijc.27958
2. Yusof AS, Isa ZM, Shah SA (2012) Dietary patterns and risk of colorectal cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer Prev 13:4713-4717
3. Dilis V, Katsoulis M, Lagiou P et al (2012) Mediterranean diet and CHD: the Greek European prospective investigation into cancer and nutrition cohort. Br J Nutr 108:699-709. doi:10.1017/S0007114512001821
4. Buckland G, Travier N, Barricarte A et al (2012) Olive oil intake and CHD in the European prospective investigation into cancer and nutrition Spanish cohort. Br J Nutr 108:2075-2082. doi:10.1017/S000711451200298X
5. Ahluwalia N, Andreeva VA, Kesse-Guyot E, Hercberg S (2012) Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab. doi:10.1016/j.diabet.2012.08.007
6. Viscogliosi G, Cipriani E, Liguori ML et al (2013) Mediterranean dietary pattern adherence: associations with prediabetes, metabolic syndrome, and related micro inflammation. Metab Syndr Relat Disord. doi:10.1089/met.2012.0168
7. Johnell O, Gullberg B, Allander E, Kanis DJA (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int 2:298-302. doi:10.1007/BF01623186
8. Kanis JA (1993) The incidence of hip fracture in Europe. Osteoporos Int 3:10-15. doi:10.1007/BF01621853
9. Benetou V, Orfanos P, Pettersson-Kymmer U et al (2012) Mediterranean diet and incidence of hip fractures in a European cohort. Osteoporos Int 24:1587-1598. doi:10.1007/s00198-012-2187-3
10. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J et al (2011) Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des 17:769-777. doi:10.2174/138161211795428948
11. Lopez S, Bermudez B, Varela LM et al (2012) Olives and olive oil: diet and health impacts. CAB Rev. doi:10.1079/PAVSNNR20127034
12. Covas M-I (2007) Olive oil and the cardiovascular system. Pharmacol Res 55:175-186. doi:10.1016/j.phrs.2007.01.010
13. Cicerale S, Conlan XA, Sinclair AJ, Keast RSJ (2008) Chemistry and health of olive oil phenolics. Crit Rev Food Sci Nutr 49:218-236. doi:10.1080/ 10408390701856223
14. Puel C, Quintin A, Agalias A et al (2004) Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammationinduced bone loss in the ovariectomised rat. Br J Nutr 92:119-127. doi:10.1079/BJN20041181 (Pubitemid 38961280)
15. Puel C, Mathey J, Agalias A et al (2006) Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin Nutr 25:859-868. doi:10.1016/j.clnu.2006.03.009 (Pubitemid 44458163)
16. Puel C, Mardon J, Kati-coulibaly S et al (2007) Black Lucques olives prevented bone loss caused by ovariectomy and talc granulomatosis in rats. Br J Nutr 97:1012-1020. doi:10.1017/S0007114507659030 (Pubitemid 46554417)
17. Puel C, Mardon J, Agalias A et al (2008) Major phenolic compounds in olive oil modulate bone loss in an ovariectomy/inflammation experimental model. J Agric Food Chem 56:9417-9422. doi:10.1021/jf801794q
18. Saleh NK, Saleh HA (2011) Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complem Altern Med 11:10. doi:10.1186/1472-6882-11-10
19. Hagiwara K, Goto T, Araki M et al (2011) Olive polyphenol hydroxytyrosol prevents bone loss. Eur J Pharmacol 662:78-84. doi:10.1016/j.ejphar.2011.04.023
20. Santiago-Mora R, Casado-Díaz A, Castro MDD, Quesada-Gómez JM (2011) Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow. Osteoporos Int 22:675-684. doi:10.1007/s00198-010-1270-x
21. Beauchamp GK, Keast RSJ, Morel D et al (2005) Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437:45-46. doi:10.1038/437045a (Pubitemid 41613421)
22. Smith AB, Han Q, Breslin PAS, Beauchamp GK (2005) Synthesis and assignment of absolute configuration of (-)-oleocanthal: a potent, naturally occurring non-steroidal anti-inflammatory and anti-oxidant agent derived from extra virgin olive oils. Org Lett 7:5075-5078. doi:10.1021/ol052106a (Pubitemid 41579931)
23. Iacono A, Gómez R, Sperry J et al (2010) Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum 62:1675-1682. doi:10.1002/art. 27437
24. Scotece M, Gómez R, Conde J et al (2012) Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1a and IL-6 in J774 macrophages and in ATDC5 chondrocytes. Life Sci 91:1229-1235. doi:10.1016/j.lfs.2012.09.012
25. Cicerale S, Lucas L, Keast R (2012) Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil. Curr Opin Biotechnol 23:129-135. doi:10.1016/j.copbio.2011.09.006
26. Pitt J, Roth W, Lacor P et al (2009) Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol 240:189-197. doi:10.1016/j.taap. 2009.07.018
27. Li W, Sperry JB, Crowe A et al (2009) Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J Neurochem 110:1339-1351. doi:10.1111/j.1471-4159.2009.06224.x
28. Monti MC, Margarucci L, Tosco A et al (2011) New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component. Food Funct 2:423-428. doi:10.1039/C1FO10064E
29. Monti MC, Margarucci L, Riccio R, Casapullo A (2012) Modulation of Tau protein fibrillization by oleocanthal. J Nat Prod 75:1584-1588. doi:10.1021/np300384h
30. Abuznait AH, Qosa H, Busnena BA et al (2013) Olive-oil-derived oleocanthal enhances b-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease. In vitro and in vivo studies. ACS Chem Neurosci. doi:10.1021/cn400024q
31. Khanal P, Oh W-K, Yun HJ et al (2011) p-HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis. Carcinogenesis 32:545-553. doi:10.1093/carcin/bgr001
32. Elnagar A, Sylvester P, El Sayed K (2011) (-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers. Planta Med 77:1013-1019. doi:10.1055/s-0030-1270724
33. Parzonko A, Naruszewicz M (2012) Oleacein protects endothelial progenitor cells against angiotensin II - induced oxidative stress. Planta Med. doi:10.1055/s-0032-1320446
34. Kanakis P, Termentzi A, Michel T et al (2012) From drupes to olive oil: how do bioactives variate during a single production procedure? Planta Med. doi:10.1055/s-0032-1321201
35. Nelson HD Menopause. The Lancet 371:760-770. doi: 10.1016/S0140-6736(08) 60346-3
36. (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser 843:1-129
37. (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17:1-45
38. Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467-475. doi:10.1016/j.bone.2007.11. 001
39. Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-191
40. Turner RT, Maran A, Lotinun S et al (2001) Animal models for osteoporosis. Rev Endocr Metab Disord 2:117-127 (Pubitemid 33643898)
41. Jee WS, Yao W (2001) Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 1:193-207
42. Lelovas PP, Xanthos TT, Thoma SE et al (2008) The laboratory rat as an animal model for osteoporosis research. Comp Med 58:424-430
43. Andreadou I, Iliodromitis EK, Mikros E et al (2006) The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 136:2213-2219 (Pubitemid 44156827)
44. Agalias A, Magiatis P, Skaltsounis A-L et al (2007) A new process for the management of olive oil mill waste water and recovery of natural antioxidants. J Agric Food Chem 55:2671-2676. doi:10.1021/jf063091d (Pubitemid 46623764)
45. Karkoula E, Skantzari A, Melliou E, Magiatis P (2012) Direct measurement of oleocanthal and oleacein levels in olive oil by quantitative 1H NMR. establishment of a new index for the characterization of extra virgin olive oils. J Agric Food Chem 60:11696-11703. doi:10.1021/jf3032765
46. Bouxsein ML, Boyd SK, Christiansen BA et al (2010) Guidelines for assessment of bone microstructure in rodents using microcomputed tomography. J Bone Miner Res 25:1468-1486. doi:10.1002/jbmr.141
47. Sirianni R, Chimento A, De Luca A et al (2010) Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res 54:833-840. doi:10.1002/mnfr.200900111
48. Kuiper GGJM, Carlsson B, Grandien K et al (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870. doi:10.1210/en.138.3.863 (Pubitemid 27089735)
49. Kuiper GGJM, Lemmen JG, Carlsson B et al (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263. doi:10.1210/en.139.10.4252 (Pubitemid 28513713)
50. Trichopoulou A, Georgiou E, Bassiakos Y et al (1997) Energy intake and monounsaturated fat in relation to bone mineral density among women and men in Greece. Prev Med 26:395-400. doi:10.1006/pmed1997.0160 (Pubitemid 27200476)
51. Wauquier F, Philippe C, Leotoing L et al (2013) The free fatty acid receptor G protein-coupled receptor 40 (GPR40) Protects from bone loss through inhibition of osteoclast differentiation. J Biol Chem 288:6542-6551. doi:10.1074/jbc.M112.429084